21 October 2016: Abingdon, UK - Genefirst Limited, a molecular diagnostics company working in fields of Infectious Diseases and Personalised medicine reported that it has received ISO 13485:2003 certification for its laboratories based in Abingdon, Oxfordshire.

The company holds a rich portfolio of patents for MPA (Multiple Probe Amplification), MMD-PCR (Multiplex Mutation Detection PCR), PCDR (Polymerase Chain Displacement Reaction) and other Next-Gen sequencing techniques. The CEO of Genefirst, Dr Guoliang Fu, said “Achieving ISO 13485 is a major milestone for the company. It reiterates our commitments towards providing high quality and robust products in molecular diagnostics. We now look forward to CE mark our first kit in HPV detection”.